Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: hameln pharma plus gmbh, Langes Feld 13, 31789, Hameln, Germany
Granisetron 1 mg/ml concentrate for solution for injection or infusion.
Pharmaceutical Form |
---|
Concentrate for solution for injection or infusion. The solution for injection is a clear, colourless liquid. |
The active substance is granisetron hydrochloride.
1ml concentrate for solution for injection or infusion contains 1.12 mg granisetron hydrochloride equivalent to 1 mg granisetron.
3 ml concentrate for solution for injection or infusion contains 3.36 mg granisetron hydrochloride equivalent to 3 mg granisetron.
This medicine contains:
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Granisetron |
Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. |
List of Excipients |
---|
Sodium chloride |
1 and 3 ml colourless ampoules.
Pack sizes: 5 × 1 ml, 10 × 1 ml, 5 × 3 ml and 10 × 3 ml
Not all pack sizes may be marketed.
hameln pharma plus gmbh, Langes Feld 13, 31789, Hameln, Germany
PL 25215/0019
Date of first authorisation: 04/07/2008
Date of latest renewal: 11/05/2013
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.